Thomas E. Pardun - 01 May 2025 Form 4 Insider Report for MAXLINEAR, INC (MXL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 May 2025, 19:48:10 UTC
Prior SEC filing
24 May 2024
Next SEC filing
10 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Connie Kwong, as Attorney-in-Fact

Key filing fact

Thomas E. Pardun filed Form 4 for MAXLINEAR, INC (MXL) on 05 May 2025.

Key facts

  • This page summarizes Thomas E. Pardun's Form 4 filing for MAXLINEAR, INC (MXL).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 May 2025, 19:48.

Change

  • Previous filing in this sequence was filed on 24 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001232833 Primary reporting owner

PARDUN THOMAS E

Relationship
Director
Address
C/O MAXLINEAR, INC., 5966 LA PLACE COURT, SUITE 100, CARLSBAD
Signature
/s/ Connie Kwong, as Attorney-in-Fact
Signature date
05 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MXL transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+12,141
Change %
+18%
Price
$0.000000
Shares after
78,393
Date
01 May 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MXL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-12,141
Change %
-100%
Price
$0.000000
Shares after
0
Date
01 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,141
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.

Footnote F2

One hundred percent (100%) of the RSUs subject to the award vested on May 1, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .